Cyclerion Therapeutics, Inc.
sGC STIMULATORS

Last updated:

Abstract:

The present disclosure relates to stimulators of soluble guanylate cyclase (sGC), pharmaceutical formulations comprising them and their uses thereof, alone or in combination with one or more additional agents, for treating various diseases, wherein an increase in the concentration of nitric oxide (NO) or an increase in the concentration of cyclic Guanosine Monophosphate (cGMP), or both, or an upregulation of the NO pathway is desirable. The compounds are of Formula I: ##STR00001##

Status:
Application
Type:

Utility

Filling date:

4 Dec 2020

Issue date:

25 Mar 2021